Literature DB >> 6180013

Monoclonal antibodies to streptococcal group A carbohydrate. I. A dominant idiotypic determinant is located on Vk.

M H Nahm, B L Clevinger, J M Davie.   

Abstract

In an effort to better define the antibody repertoire to streptococcal group A carbohydrate (GAC), somatic cell hybrids were prepared from A/J mice immunized with streptococcal vaccine. Most antibodies were IgG3K and IgMK, while 2 of 26 antibodies were lambda type. Each of the IgG3 antibodies had a distinct isoelectric point consistent with previous estimates of clonal repertoires of approximately 200. IEF analysis of the L chains, however, showed that about half of the antibodies produce a common L chain, called VK1GAC, previously identified in A/J anti-GAC serum antibodies. Additional support for the structural similarity of these L chains was gained by developing an idiotype antiserum to VK1GAC. All proteins with the common L chain spectrotype react strongly with anti-VK1GAC. Thus, it appears that anti-GAC antibodies are composed of H chains bearing a few VH regions pairing with a few L chains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180013

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  T-Cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin.

Authors:  S Malkiel; L Liao; M W Cunningham; B Diamond
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies.

Authors:  S L Harris; L Craig; J S Mehroke; M Rashed; M B Zwick; K Kenar; E J Toone; N Greenspan; F I Auzanneau; J R Marino-Albernas; B M Pinto; J K Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

3.  Molecular dissection of the murine antibody response to streptococcal group A carbohydrate.

Authors:  C T Lutz; T L Bartholow; N S Greenspan; R J Fulton; W J Monafo; R M Perlmutter; H V Huang; J M Davie
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

4.  Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies.

Authors:  J R Turner; A M Tartakoff; N S Greenspan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Construction of an extended three-dimensional idiotope map by electron microscopic analysis of idiotope-anti-idiotope complexes.

Authors:  K H Roux; W J Monafo; J M Davie; N S Greenspan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 6.  Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction.

Authors:  N S Greenspan; L J Cooper
Journal:  Springer Semin Immunopathol       Date:  1993

7.  Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.

Authors:  J S Shin; J S Lin; P W Anderson; R A Insel; M H Nahm
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency.

Authors:  K H Kim; M K Park; C C Peeters; J T Poolman; M H Shearer; R C Kennedy; M H Nahm
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Adjuvant arthritis is associated with changes in the glycosylation of serum IgG1 and IgG2b.

Authors:  H Yagev; A Frenkel; I R Cohen; A Friedman
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

10.  Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.

Authors:  Nicholas W Kin; Emily K Stefanov; Brian L P Dizon; John F Kearney
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.